Research & Development

Groundbreaking research involving more than twenty thousand oncology patients has finally pulled back the curtain on a quiet crisis where medical treatments are inadvertently failing to account for the fundamental biological differences between men and women. For decades, the medical community

The relentless physical and psychological burden of chronic cholestatic pruritus often defines the daily existence of patients long before a clinical diagnosis is even finalized. For those living with rare liver diseases, the sensation of an internal, unreachable itch is not merely a symptom but a

Pediatric liver cancer research has entered a transformative era with the identification of Hepatoblastoma with carcinoma features (HBC), a complex third category that bridges the gap between traditional hepatoblastoma and hepatocellular carcinoma. Ivan Kairatov, a biopharma expert with extensive

The boundaries between how a cell generates energy and how it decides to multiply have long been viewed as separate chapters in the book of biology, yet recent evidence suggests these processes are inextricably linked by a single, versatile protein. For over seventy years, scientists categorized

The current oncology landscape is defined by an urgent need for therapies that can bypass resistance mechanisms in advanced breast cancer while maintaining patient quality of life. Pfizer’s latest clinical data for atirmociclib suggests a significant advancement in achieving this balance through a

The high-stakes landscape of biotechnology often demands that even the most innovative firms execute sudden, clinical-grade course corrections to ensure their long-term survival. Bicycle Therapeutics recently demonstrated this reality by announcing a drastic shift in its corporate strategy, which